01 1Cambrex Corporation
01 1TERBUTALINE SULFATE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-02
Pay. Date : 2013-03-27
DMF Number : 11927
Submission : 1996-04-17
Status : Active
Type : II
20
Cambrex Profarmaco Milano Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.
One of their notable products is TERBUTALINE SULFATE, with a corresponding US DMF Number 11927.
Remarkably, this DMF maintains an Active status since its submission on April 17, 1996, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 02, 2013, and payment made on March 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
